Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Oncogene·2020

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Psychological medicine·2016

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Oncogene·2013

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

British journal of cancer·2013

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Clinical pharmacology and therapeutics·2013

Epithelial cell plasticity in neoplasia.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

A role for cholinesterases in tumorigenesis?

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991

Targeting CKIP-1 for Disease Therapy: Cellular Functions, Molecular Networks, and Clinical Potential.

Cell proliferation·2026

YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

An Immune-Activated Co-culture Model of Patient-Derived Gastric Cancer Organoids and Peripheral Blood Mononuclear Cells for Personalized Chemotherapy Screening.

Acta biomaterialia·2026

Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.

Pharmacological research·2026

Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.

ACS chemical biology·2026

Related Experiment Videos

Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity

Related Concept Videos

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Epithelial cell plasticity in neoplasia.

Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.

JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine.

A role for cholinesterases in tumorigenesis?

The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.

New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.

Targeting CKIP-1 for Disease Therapy: Cellular Functions, Molecular Networks, and Clinical Potential.

YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.

Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.

An Immune-Activated Co-culture Model of Patient-Derived Gastric Cancer Organoids and Peripheral Blood Mononuclear Cells for Personalized Chemotherapy Screening.

Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.

Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.

Related Experiment Videos

Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity

Related Concept Videos

Related Articles